Literature DB >> 16476717

Renoprotection of angiotensin receptor blockers: beyond blood pressure lowering.

Toshio Miyata, Charles van Ypersele de Strihou.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16476717     DOI: 10.1093/ndt/gfl013

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

Review 1.  Management of hypertension in chronic kidney disease.

Authors:  Pasquale Zamboli; Luca De Nicola; Roberto Minutolo; Valerio Bertino; Fausta Catapano; Giuseppe Conte
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

Review 2.  Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications.

Authors:  Ryoji Nagai; David B Murray; Thomas O Metz; John W Baynes
Journal:  Diabetes       Date:  2012-03       Impact factor: 9.461

3.  Physician adherence to hypertension treatment guidelines and drug acquisition costs of antihypertensive drugs at the cardiac clinic: a pilot study.

Authors:  Shaymaa Abdalwahed Abdulameer; Mohanad Naji Sahib; Noorizan Abd Aziz; Yahaya Hassan; Hadeer Akram Abdul Alrazzaq; Omar Ismail
Journal:  Patient Prefer Adherence       Date:  2012-01-31       Impact factor: 2.711

4.  Evolving pandemic diabetic nephropathy.

Authors:  Eli A Friedman
Journal:  Rambam Maimonides Med J       Date:  2010-07-02

5.  Is there really good news about pandemic diabetic nephropathy?

Authors:  Eli A Friedman; Amy L Friedman
Journal:  Nephrol Dial Transplant       Date:  2007-01-05       Impact factor: 5.992

6.  Advances in Clinical Research in Chronic Kidney Disease.

Authors:  Yutong Zou; Fang Liu; Mark E Cooper; Zhonglin Chai
Journal:  J Transl Int Med       Date:  2021-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.